C12Y 207/12001
Dual-specificity kinase
Official title: Dual-specificity kinase (2.7.12.1)
C12Y207/12001 (Dual-specificity kinase) appears on 5 US grants and 12 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 12
- Assignees
- 12
- Inventors
- 28
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 2 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 2 |
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Tumor antigen peptide26 May 2026US 12,637,500 B2Niigata University
- Peptides and uses thereof for treating cancer12 Mar 2024US 11,926,677 B2Symthera Canada Ltd.
- Compositions and methods for regulating activity of inhibitor of DNA binding-2 (ID2) protein and for treating ID protein-related diseases29 Jun 2021US 11,045,525 B2The Trustees of Columbia University in the City of New York
- Green microalgae lacking a functional DYRKP-1 gene, for use for increased production of feedstock24 Dec 2019US 10,513,680 B2Commissariat A L' Energie Atomique Et Aux Energies Alternatives
- Dosage compensating transgenes and cells26 Jun 2018US 10,004,765 B2University of Massachusetts
- Compositions and methods to modulate tumor microenvironment associated long noncoding rnas23 Apr 2026US 2026/0109988 A1HAYA Therapeutics SA
- Polynucleotide for treatment of neurodegenerative disease, vector, cell, pharmaceutical composition, and screening method11 Sep 2025US 2025/0281642 A1Riken
- Novel peptides and uses thereof for treating cancer12 Sep 2024US 2024/0301002 A1Symthera Canada Ltd.
- Proline hydroxylation primes protein kinases for autophosphorylation and activation4 May 2023US 2023/0138177 A1The Trustees of Columbia University in the City of New York
- Novel peptides and uses thereof for treating cancer24 Jun 2021US 2021/0188910 A1Symthera Canada Ltd.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.